UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000028594
Receipt No. R000032729
Scientific Title Phase II clinical trial of the combination of eribulin and trastuzumab for advanced/recurrent HER2-positive breast cancer: observational study
Date of disclosure of the study information 2017/08/09
Last modified on 2018/10/10 12:57:58

No. Disposal Last modified on Item of update
1 Insert 2017/08/09 10:33:40
2 Update 2018/10/10 12:57:58 Recruitment status
Publication of results


Contact us.